ロード中...
SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
OBJECTIVES: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) produced good tumor response in cases with lung squamous cell carcinoma, one of the most difficult cancers to treat. Secreted protein acidic and rich in cysteine (SPARC) binds to albumin, suggesting that SPARC plays an important role...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5089830/ https://ncbi.nlm.nih.gov/pubmed/27822069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114492 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|